Jessurun, Naomi T.
Drent, Marjolein http://orcid.org/0000-0003-1586-0110
Wijnen, Petal A.
Harmsze, Ankie M.
van Puijenbroek, Eugène P.
Bekers, Otto
Bast, Aalt
Clinical trials referenced in this document:
Documents that mention this clinical trial
Role of Drug–Gene Interactions and Pharmacogenetics in Simvastatin-Associated Pulmonary Toxicity
https://doi.org/10.1007/s40264-021-01105-8
Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease
https://doi.org/10.1007/s40264-024-01400-0
Article History
Accepted: 28 July 2021
First Online: 4 October 2021
Declarations
:
: This research received no external funding.
: The authors declare no conflict of interest.
: The study was conducted according to the principles of the Declaration of Helsinki (version 5, 2004) and in accordance with the Dutch Medical Research Involving Human Subjects Act (WMO). The protocol was approved by the Medical research Ethics Committees United (MEC-U) of the St. Antonius Hospital (approval R05-08A). The study protocol was approved by the Ethics Committee.
: All participants provided written informed consent.
: Not applicable.
: Anonymized data can be made available to investigators upon request to the corresponding author.
: Not applicable.
: All authors read and approved the final version. Conceptualization: NTJ, MD, and AB; data curation: MD, PAW, and AMH; methodology: NTJ, MD, PAW, and AMH: writing—original draft: NTJ, MD and AB; writing—review and editing: NTJ, MD, PAW, AMH, EPP, OB, and AB.